Clinical Trials Browser

Phase 2 × Not yet recruiting × ARX788 × Clear all

NCT06224673 2026-02-13

ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer

Phase 2 Not yet recruiting

Triple Negative Breast Neoplasms

NCT06663748 2024-10-29

ARX788 in HER2-positive Metastatic Breast Cancer Patients

Phase 2 Not yet recruiting

Breast Neoplasms